舒芬太尼复合丙泊酚用于宫颈癌根治术的麻醉效果分析(1)
【摘 要】 目的:观察并探讨舒芬太尼复合丙泊酚用于宫颈癌根治术的麻醉效果。 方法:选取84例于2014年12月——2018年12月期间来我院行宫颈癌根治术的患者,按患者就诊顺序分为对照组与实验组,人数相同各42例,所有患者均给予丙泊酚联合舒芬太尼麻醉,实验组与对照组患者的舒芬太尼药物使用剂量分别为0.30ng/mL、0.20 ng/mL,对两组患者的血流动力学指标以及术后VAS评分进行观察与对比。 结果:实验组患者在插管即刻、插管后一分钟以及拔管时的心率及平均动脉压与对照组结果比较均显著较低,实验组患者术后VAS评分显著低于对照组,差异具有统计学意义,P<0.05。 结论:在宫颈癌根治术中应用丙泊酚复合舒芬太尼靶控输注具有确切麻醉效果,值得推广应用。【关键词】 宫颈癌根治术;靶控输注;丙泊酚;舒芬太尼;麻醉效果
【中图分类号】R821.4+1
【文献标志码】A
【文章编号】 1005-0019(2019)14-008-01
Abstract Objective: To observe and explore the anesthetic effect of sufentanil combined with propofol for radical resection of cervical cancer. Methods: Eighty-four patients who underwent radical resection of cervical cancer in our hospital from December 2014 to December 2018 were enrolled. The patients were divided into the control group and the experimental group according to the order of the patients. The number of patients was the same in 42 cases. All patients were given C. Paclitaxel combined with sufentanil anesthesia ......
您现在查看是摘要页,全文长 3363 字符。